The Basics of Cancer Immunotherapy

This book provides patients and their physicians (especially "non-oncologist" health care providers) with a clear and concise introduction to cancer immunotherapy, which, unlike traditional forms of cancer therapy, acts by boosting the patient's own immune system to fight cancer. The...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Dong, Haidong (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Markovic, Svetomir N. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2018.
Έκδοση:1st ed. 2018.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04625nam a2200493 4500
001 978-3-319-70622-1
003 DE-He213
005 20191025061231.0
007 cr nn 008mamaa
008 180105s2018 gw | s |||| 0|eng d
020 |a 9783319706221  |9 978-3-319-70622-1 
024 7 |a 10.1007/978-3-319-70622-1  |2 doi 
040 |d GrThAP 
050 4 |a R-RZ 
072 7 |a VFD  |2 bicssc 
072 7 |a MED000000  |2 bisacsh 
072 7 |a VFD  |2 thema 
082 0 4 |a 610  |2 23 
245 1 4 |a The Basics of Cancer Immunotherapy  |h [electronic resource] /  |c edited by Haidong Dong, Svetomir N. Markovic. 
250 |a 1st ed. 2018. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2018. 
300 |a X, 160 p. 8 illus., 4 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a The Basic Concepts in Cancer Immunology and Immunotherapy -- Therapeutic Targets of FDA-approved Immunotherapies in Oncology -- Melanoma Immunotherapy -- Significance of Immune Checkpoints in Lung Cancer -- Immunotherapy for Genitourinary Cancers -- Next-generation Immunotherapy in Lymphoma Immunotherapy -- Combined Immunothepary with Conventional Cancer Treatment -- Immunotherapy for Other Malignancies -- Management of Immune-related Adverse Events from Immune Checkpoint Inhibitor Therapy -- Resources for Patients. 
520 |a This book provides patients and their physicians (especially "non-oncologist" health care providers) with a clear and concise introduction to cancer immunotherapy, which, unlike traditional forms of cancer therapy, acts by boosting the patient's own immune system to fight cancer. The unique features of cancer immunotherapy make its management, monitoring and side-effects different from those of traditional cancer therapy. Especially novel are the side effects of cancer immunotherapy, necessitating greater awareness for both patients and physicians in order to minimize complications of therapy.    The patient-friendly, concise, easy-to-understand, and up-to-date knowledge presented in this book will inform patients about the benefits and risks of cancer immunotherapy, and help them and their care providers to understand how immunotherapy would control their unique disease.   Researchers and academic professionals in the field of cancer immunotherapy will also find clear and useful information to help them communicate with patients or address unresolved problems.  Some key features of the book are: Expertise. All editors and authors are scientists and oncologists specializing in cancer immunotherapy, and are involved in scientific discovery from the early stage of immune-checkpoint inhibitors to today's daily patient care. Their insights, expertise and experience guarantee the high quality and authority in the science, medicine and practice of cancer immunotherapy. Patient-friendly. This book is written for cancer patients in order to meet their needs when considering immunotherapy. As an educational tool, this book will help the reader balance the risks and benefits based on both science and clinical facts, and therefore to make the best choice in receiving or withdrawing from immunotherapy. Disease Specificity. Cancer is a complicated disease involving multiple stages and pathology. Its response to immunotherapy is individualized and varies depending on cancer types. The authors' expertise in treating different types of cancers, including melanoma, lung, kidney,  bladder, and lymphoma, provides disease-specific insights in applying immunotherapy to each disease. 
650 0 |a Medicine . 
650 0 |a Health. 
650 0 |a Immunology. 
650 0 |a Cancer research. 
650 1 4 |a Popular Science in Medicine and Health.  |0 http://scigraph.springernature.com/things/product-market-codes/Q14008 
650 2 4 |a Immunology.  |0 http://scigraph.springernature.com/things/product-market-codes/B14000 
650 2 4 |a Cancer Research.  |0 http://scigraph.springernature.com/things/product-market-codes/B11001 
700 1 |a Dong, Haidong.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Markovic, Svetomir N.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319706214 
776 0 8 |i Printed edition:  |z 9783319706238 
856 4 0 |u https://doi.org/10.1007/978-3-319-70622-1  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)